Rekombinanter IL17A (Secukinumab Biosimilar) Antikörper

Produktnummer ABIN7795097

Dieser Humanized Monoklonal Antikörper detektiert spezifisch IL17A (Secukinumab Biosimilar) in FACS und in vivo. Es zeigt Reaktivität gegenüber Proben von Human.

Kurzübersicht für Rekombinanter IL17A (Secukinumab Biosimilar) Antikörper (ABIN7795097)

Target: IL17A (Secukinumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Humanized

Klonalität: Monoklonal

Konjugat: Dieser IL17A (Secukinumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), In vivo Studies (in vivo)

Güteklasse: Research Grade

Produktdetails anti-IL17A (Secukinumab Biosimilar) Antikörper

Expressionssystem: Mammalian cells

Verwendungszweck: Secukinumab Biosimilar, Human IL17A Monoclonal Antibody

Produktmerkmale: What is secukinumab biosimilar research grade? Research grade secukinumab biosimilar uses the same protein sequences as the therapeutic antibody secukinumab. Secukinumab, the humanized anti-IL17A monoclonal antibody, inhibits interleukin 17A, which is a member of the cytokine family, and produced mainly by inflammatory T helper 17 cells. IL17A is upregulated in serum of people with psoriasis and in the synovial fluid of people with psoriatic arthritis, and promotes inflammation when it binds to the interleukin-17 receptor which is expressed in various types of cells, including keratinocytes in skin.

Aufreinigung: Protein A or G affinity column

Reinheit: >95 % by reducing SDS-PAGE

Endotoxin-Niveau: < 1 EU per 1 mg of the protein by the LAL method

Immunogen: Human IL17A

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: > 3 mg/mL

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Details zu IL17A (Secukinumab Biosimilar)

Target: IL17A (Secukinumab Biosimilar)

Andere Bezeichnung: Secukinumab Biosimilar

Substanzklasse: Biosimilar